Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
US Equity | 97.8% |
---|---|
Int'l Equity | 2.3% |
CDN Equity | 0 |
Fixed Income | 0 |
Other | 0 |
Cash | -0.1% |
Healthcare | 99.3% |
---|---|
Industrials | 0.8% |
Basic Mat. | 0 |
Communication Services | 0 |
Consumer Cyclical | 0 |
Consumer Defensive | 0 |
Energy | 0 |
Financial Serv.s | 0 |
Real Estate | 0 |
Technology | 0 |
Utilities | 0 |
United States | 97.7% |
---|---|
Latin America | 0 |
Africa | 0 |
Asia/Oceania | 0 |
Canada | 0 |
Europe | 0 |
Company Name sortable | Position sortable | Allocation sortable | Allocation sortable1 Month Change | Market Value sortable |
---|---|---|---|---|
Roivant Sciences Ltd Ordinary Shares | Long | 2.3% | +96.16% | $326.8K |
United Therapeutics Corp | Long | 2.3% | +5.71% | $322.3K |
Natera Inc | Long | 2.3% | -24.33% | $320.9K |
Shockwave Medical Inc | Long | 2.2% | --- | $320.5K |
Encompass Health Corp | Long | 2.2% | +11.56% | $319.1K |
DaVita Inc | Long | 2.2% | +4.79% | $318.2K |
Eli Lilly and Co | Long | 2.2% | +3.51% | $317.2K |
The Cigna Group | Long | 2.2% | -8.93% | $310.6K |
Viatris Inc | Long | 2.1% | +0.20% | $306.2K |
Medpace Holdings Inc | Long | 2.1% | -16.22% | $303.7K |
Time Horizon | Star Rating |
---|---|
Overall Rating | Not Rated |
3 Year Rating | Not Rated |
5 Year Rating | Not Rated |
10 Year Rating | Not Rated |
Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.
Style Box is calculated only using the long position holdings of the portfolio.
Best Fit Index | --- |
---|---|
Category | Sector Equity |
Sponsor | First Trust Advisors L.P. |
Inception | October 29, 2014 |
First Trust AlphaDEXâ„¢ U.S. Health Care Sector Index ETF, First Trust AlphaDEXâ„¢ U.S. Industrials Sector Index ETF and First Trust AlphaDEXâ„¢ U.S. Technology Sector Index ETF Each of the StrataQuant® Health Care Index, StrataQuant® Industrials Index and StrataQuant® Technology Index (the “StrataQuant Indicesâ€) results from applying the AlphaDEXâ„¢ methodology to the Russell 1000® Index, a market index representing the large and mid-capitalization segment of the U.S. equity universe, and then selecting the Constituent Securities for the StrataQuant Index from those qualifying stocks included in the applicable Sector.
Total Net Assets | $11.5M |
---|---|
Shares Out. | 300.0K |
Net Asset Value (NAV) | $38.80 |
Prem/Discount to NAV | -0.22% |
P/E Ratio | 17.9 |
Dividend Yield | 0.30% |
Dividend per Share | 0.12 CAD |
Ex-Dividend Date | 03/27/2024 |
Dividend Payment Date | 04/5/2024 |
Beta | --- |
Morningstar Investment Style | Sector Equity |
Equity Style | Mid Cap Blend |
Credit Quality / Duration | --- |
Actual Management Fee | 0.70% |
---|---|
Actual Mgmt. Expense Ratio (MER) | 0.76% |